- AMD agreed to acquire Fei-Fei Li’s World Labs for about $8.2 billion in an all-stock deal, Bloomberg reported.
- Fei-Fei Li, World Labs’ cofounder and CEO, will become AMD executive vice president and chief scientist, reporting directly to CEO Lisa Su.
- World Labs builds “world models” that generate, reconstruct, and simulate interactive 3D environments from text, image, and video inputs, plus robotics-simulation technology.
- The deal, expected to close by the end of 2026, is AMD’s second-largest ever after its roughly $50 billion Xilinx acquisition.
What Happened
AMD agreed on September 28, 2026 to acquire World Labs for about $8.2 billion in an all-stock deal, according to Bloomberg’s report from that day. Fei-Fei Li, the startup’s cofounder and CEO, will become AMD’s executive vice president and chief scientist after the deal closes, reporting directly to CEO Lisa Su.
Why It Matters
AMD had already invested in World Labs’ $1 billion funding round in February 2026, and the two companies were working together to optimize training and inference for its models — part of a broader AMD push into AI partnerships that also includes its up to $5 billion commitment to supply Anthropic with Instinct GPUs.
Technical Details
World Labs develops spatial-intelligence models that generate, reconstruct, and simulate interactive 3D environments from text, image, and video inputs, along with technology for robotic learning and simulation. The roughly $8.2 billion price makes it AMD’s second-largest acquisition after its approximately $50 billion purchase of Xilinx, which closed in 2022.
Who’s Affected
AMD gains an in-house AI research lab and Li’s leadership team; World Labs’ staff transition into AMD. The move follows a wider wave of chipmakers buying AI labs outright, including Nvidia’s $12.9 billion acquisition of Hugging Face and Marvell’s purchase of Celestial AI.
What’s Next
The deal is expected to close by the end of 2026, subject to regulatory approvals and customary closing conditions. AMD has not yet detailed Li’s specific research mandate beyond the chief-scientist title.
